Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Functional Connectome in Prader-Willi Syndrome: Integrating Neuroimaging and Artificial Intelligence to Assess the Impact of Physiological and Therapeutic Interventions

NCT06900335 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT06900335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06900335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Functional Connectome in Prader-Willi Syndrome: Integrating Neuroimaging and Artificial Intelligence to Assess the Impact of Physiological and Therapeutic Interventions
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
March 1, 2025
Completion date
March 15, 2025
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behavior disorders, hyperphagia, prader willi syndrome